USAEUROPEViVE
ABOUTSPONSORSHIPFOUNDATION
Logo Hlth
Logo Hlth
24 May 2022 | 07:00 AM GMT

Adoption of Prescription DTx: Best Practices & Challenges

Participants:

Anish Shindore Founder & Managing PartnerGSD Health
Anish Shindore
Founder & Managing PartnerGSD Health
Arthur Bretonnet Global Digital Innovation LeadUCB Pharma
Arthur Bretonnet
Global Digital Innovation LeadUCB Pharma
Caroline Beaufour Innovation LeadServier
Caroline Beaufour
Innovation LeadServier
Hannes Klöpper FounderHelloBetter
Hannes Klöpper
FounderHelloBetter
Helen Hey Director Business StrategyMerakoi
Helen Hey
Director Business StrategyMerakoi
Karine Soulat Marketing Consultant on health and e healthKe-Health
Karine Soulat
Marketing Consultant on health and e healthKe-Health
Maxime Champain Search & Evaluation lead, External InnovationBiogen
Maxime Champain
Search & Evaluation lead, External InnovationBiogen
Polina Veltmann Co-founder & CEOOrly Health
Polina Veltmann
Co-founder & CEOOrly Health
Renato De Giorgi Managing PartnerBeyond Parallel 32
Renato De Giorgi
Managing PartnerBeyond Parallel 32

About this Meeting

A company might be able to create excellent digital therapeutics (DTx), but it won't have much of an impact if no one uses them. Adoption, or more specifically getting patients and doctors to start using and engage with DTx products, is one of the biggest challenges for prescription DTx (PDT). In this meeting, we will look at how we can approach the problem and how some have already solved it.  

Join HealthXL in this session to discuss the following: 
 
  • How can digital health formularies, prescription platforms and/or rating systems increase the number of prescriptions of DTx by physicians?  
  • In countries where there is prescription capability (such as Germany), prescription rates remain low. What else is needed?  What is the role of other members within a care team? 
  • As prescription DTx edge closer to becoming incorporated into therapeutic arsenals, the seamless integration into Electronic Health Records (EHR) and other workflows still need to be ironed out. How can this be done in a seamless way to ensure the system works for physicians? 
  • Once a DTx is prescribed, how can we make sure that patients are motivated to start using it and complete the therapy?